Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Prolonged anesthesia and decreased toxicity of enantiomeric-excess bupivacaine loaded in ionic gradient liposomes

Full text
Author(s):
de Lima, Fernando Freitas [1] ; da Silva, Bianca Brandao [1] ; Oliveira, Juliana Damasceno [1] ; de Moura, Ludmilla David [1] ; da Silva, Gustavo Henrique Rodrigues [1] ; Fernandes, Priscila Cordeiro Lima [1] ; Souza, Roosevelt Isaias Carvalho [2] ; dos Santos, Ariany Carvalho [2] ; de Paula, Eneida [1]
Total Authors: 9
Affiliation:
[1] Univ Campinas Unicamp, Inst Biol, Dept Biochem & Tissue Biol, Campinas - Brazil
[2] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS - Brazil
Total Affiliations: 2
Document type: Journal article
Source: International Journal of Pharmaceutics; v. 606, SEP 5 2021.
Web of Science Citations: 0
Abstract

Bupivacaine is the most employed local anesthetic in surgical procedures, worldwide. Its systemic toxicity has directed the synthesis of the less toxic, S(-) enantiomer. This work describes a formulation of ionic gradient liposomes (IGL) containing S75BVC, an enantiomeric excess mixture of 75% S(-) and 25% R(+) bupivacaine. IGL prepared with 250 mM (NH4)(2)SO4 in the inner aqueous core of phosphatidylcholine and cholesterol (3:2 mol%) vesicles plus 0.5% S75BVC showed average sizes of 312.5 +/- 4.5 nm, low polydispersity (PDI < 0.18), negative zeta potentials (-14.2 +/- 0.2 mV) and were stable for 360 days. The encapsulation efficiency achieved with IGL(S75BVC) (%EE = 38.6%) was higher than with IGL prepared with racemic bupivacaine (IGL(RBVC), %EE = 28.3%). TEM images revealed spherical vesicles and mu DSC analysis provided evidence on the interaction of the anesthetic with the lipid bilayer. Then, in vitro release kinetics and cytotoxicity- and in vivo - toxic effects in Zebrafish and biochemical/histopathological analysis plus analgesia in Wistar rats tests were performed. IGL(S75BVC) exhibited negligible toxicity against Schwann cells and Zebrafish larvae, and it did not affect biochemical markers or the morphology of rat tissues (heart, brain, cerebellum, sciatic nerve). The in vitro release of S75BVC from IGL was extended from 4 to 24 h, justifying the prolonged anesthetic effect measured in rats (similar to 9 h). The advantages of IGL(S75BVC) formulation over IGL(RBVC) and plain bupivacaine formulations (prolonged anesthesia, preferential sensorial blockade, and no toxicity) confirm its potential for clinical use in surgical anesthesia. (AU)

FAPESP's process: 18/12121-0 - LIPID-BASED NANOCARRIERS FOR THE LOCAL ANESTHETIC TETRACAINE
Grantee:Fernando Freitas de Lima
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 14/14457-5 - Lipid-based nanocarriers (SLN/NLC and remote-loading liposomes) used to improve the upload and potency of local anesthetics
Grantee:Eneida de Paula
Support type: Research Projects - Thematic Grants